PUBLISHER: GlobalData | PRODUCT CODE: 1410763
PUBLISHER: GlobalData | PRODUCT CODE: 1410763
Viscosupplementation Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Orthopedic Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on the Viscosupplementation market for the year 2020 and beyond.
Viscosupplementation is a minimally invasive procedure where hyaluronic acid (an active compound in synovial fluid) is injected into the joints. The procedure is majorly carried out in the knee, followed by the hip, shoulder, ankle, and other joints.
Viscosupplementation treatment regimens have been divided into 1-injection, 3-injection, and 5-injection regimens with 3 and 5-injection treatments showing major effects in pain relief. However, for the past few there has been an ongoing controversy over its effectiveness and sustainability for OA patients. This has decreased the reimbursements given by the government and private insurance companies for treatment over the period of time.
Each of the covered 39 country's color-coded and fully-sourced market models is equipped with epidemiology-based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers the installed base, new sales volumes, product usage, average selling prices, market size, and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Viscosupplementation Devices and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Sanofi , Seikagaku Corp, Bioventus Inc, Anika Therapeutics Inc, Fidia farmaceutici SpA, Ferring Pharmaceuticals AS, Zimmer Biomet Holdings Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable